Interview with the President of IRBM, Piero Di Lorenzo «Results of Phase I clinical trials in late June»
We have one certainty: the vaccine candidate produced by IRBM in Pomezia (Rome), together with the Oxford University, is the most advanced in the world. News that make the South of Rome proud. Piero Di Lorenzo, President and CEO of IRBM, explains how much longer we have to wait: the first inoculations could already start this winter for risk groups. Di Lorenzo also clarifies whether Advent/IRBM will actually be involved in the large-scale production of the vaccine.
Article published on Latina OGGI – 20/06/2020